title: Response to letter to the editor on "Early benefit assessment of new drugs in Germany--results from 2011 to 2012" [Health Policy 116(2-3) (2014) 147-153].
authors.affiliation: Institute for Quality and Efficiency in Health Care, Im Mediapark 8, 50670 Cologne, Germany.
authors.forename: Helmut
authors.initials: H
authors.lastname: Hörn
authors.affiliation: Institute for Quality and Efficiency in Health Care, Im Mediapark 8, 50670 Cologne, Germany. Electronic address: Katrin.nink@iqwig.de.
authors.forename: Katrin
authors.initials: K
authors.lastname: Nink
authors.affiliation: Institute for Quality and Efficiency in Health Care, Im Mediapark 8, 50670 Cologne, Germany.
authors.forename: Natalie
authors.initials: N
authors.lastname: McGauran
authors.affiliation: Institute for Quality and Efficiency in Health Care, Im Mediapark 8, 50670 Cologne, Germany.
authors.forename: Beate
authors.initials: B
authors.lastname: Wieseler
mesh_terms: D017277:Drug Approval / Q000379:methods*; D006801:Humans